1Laboratory of Neurogenetics, Department of Biochemistry, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, Universiteitsplein 1, B-2610 Antwerpen, Belgium
2Laboratory of Neuropathology, Department of Medicine, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, Universiteitsplein 1, B-2610 Antwerpen, Belgium
3Department of Pathology and Neuropathology Laboratory, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
4Neuropathology Laboratory, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
5Department of Pathology, Neuroscience and Neuropathology Laboratory, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
6Corresponding Author: Lydia Hendriks
ACKNOWLEDGEMENTS: This research was supported by the Flemish Biotechnolgy Program (C.V.B.), the Fund of Scientific Research-Flanders (C.V.B.), BIOTECH (BIO2-CT94-2056) program of the European Community (C.V.B.), the Focused giving Grant program of Johnson & Johnson (C.V.B.), DWTC program-Interuniversitaire attractiepolen (IUAP) (C.V.B.). U.S. Public Health Service, National Institute of Health Grants 1PO1 AG 14248, NIH AG05146, NS 20471 (S.S.S.), and by grants from the Adler Foundation (G.T. and S.S.S.) and the Develbiss Fund (S.S.S.). S.S.S. is the recipient of an Alzheimer's Association Zenith Award. C.D.J. is an aspirant of the Fund of Scientific Research-Flanders.
Received 18 February 1997; accepted 6 March 1997
